121 related articles for article (PubMed ID: 31420918)
1. Transcription factor Six2 induces a stem cell-like phenotype in renal cell carcinoma cells.
Cheng N; Li H; Han Y; Sun S
FEBS Open Bio; 2019 Oct; 9(10):1808-1816. PubMed ID: 31420918
[TBL] [Abstract][Full Text] [Related]
2. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
[TBL] [Abstract][Full Text] [Related]
4. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.
Zheng L; Guo Q; Xiang C; Liu S; Jiang Y; Gao L; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Wang Y; Li X; Xi T
J Hematol Oncol; 2019 Mar; 12(1):23. PubMed ID: 30832689
[TBL] [Abstract][Full Text] [Related]
6. The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
Senanayake U; Koller K; Pichler M; Leuschner I; Strohmaier H; Hadler U; Das S; Hoefler G; Guertl B
Hum Pathol; 2013 Mar; 44(3):336-45. PubMed ID: 22995329
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
[TBL] [Abstract][Full Text] [Related]
8. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
[TBL] [Abstract][Full Text] [Related]
9.
Wu Y; Song T; Liu M; He Q; Chen L; Liu Y; Ni D; Liu J; Hu Y; Gu Y; Li Q; Zhou Q; Xie Y
DNA Cell Biol; 2019 Jul; 38(7):700-707. PubMed ID: 31090452
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor RNA activator inhibits the migration, invasion and stemness characteristics of renal cell carcinoma cells.
Zhang C; Zhu N; Liu C; Wu H; Yin Y; Shi Y; Liao D; Qin L
Int J Mol Med; 2020 Nov; 46(5):1765-1776. PubMed ID: 33000206
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
14. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Biomed Pharmacother; 2018 Aug; 104():204-210. PubMed ID: 29772441
[TBL] [Abstract][Full Text] [Related]
15. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
[TBL] [Abstract][Full Text] [Related]
16. Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells.
Chen K; Wei H; Pan J; Chen Z; Pan D; Gao T; Huang J; Huang M; Ou M; Zhong W
Eur J Pharmacol; 2019 Oct; 861():172599. PubMed ID: 31404537
[TBL] [Abstract][Full Text] [Related]
17. Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma.
Kobayashi G; Sentani K; Babasaki T; Sekino Y; Shigematsu Y; Hayashi T; Oue N; Teishima J; Matsubara A; Sasaki N; Yasui W
Cancer Sci; 2020 Mar; 111(3):1020-1027. PubMed ID: 31912588
[TBL] [Abstract][Full Text] [Related]
18. Role of SIRT2 in Regulation of Stemness of Cancer Stem-Like Cells in Renal Cell Carcinoma.
Wei R; He D; Zhang X
Cell Physiol Biochem; 2018; 49(6):2348-2357. PubMed ID: 30261494
[TBL] [Abstract][Full Text] [Related]
19. Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.
Song L; Ye W; Cui Y; Lu J; Zhang Y; Ding N; Hu W; Pei H; Yue Z; Zhou G
Oncotarget; 2017 May; 8(19):31977-31992. PubMed ID: 28404888
[TBL] [Abstract][Full Text] [Related]
20. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
